FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice

SIMPLE SUMMARY: FGFR inhibitors evolved as therapeutic options in cholangiocarcinoma and urothelial malignancies. Given the implications of FGFR pathway in various physiological functions, FGFR inhibitors are known to cause unique toxicities. In this review, we summarized the physiology of FGF/FGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Kommalapati, Anuhya, Tella, Sri Harsha, Borad, Mitesh, Javle, Milind, Mahipal, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231807/
https://www.ncbi.nlm.nih.gov/pubmed/34199304
http://dx.doi.org/10.3390/cancers13122968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231807/
https://www.ncbi.nlm.nih.gov/pubmed/34199304
http://dx.doi.org/10.3390/cancers13122968

Ejemplares similares